No.126 Aegon-Industrial Global Health Symposium Series
How is Real World Evidence Driving Impact in The Drug Life Cycle?
Dr. Jiachen Zhou is the RWE Lead China at UCB, a multinational biopharmaceutical company headquartered in Brussels, Belgium, where he leads the development and execution of all regional RWE related activities of the company. Previously Jiachen worked as a clinical epidemiologist at the telemedicine program of Philips Electronics North America.
Jiachen holds a Ph.D. in epidemiology from Brown University, specializing in chronic disease epidemiology, pharmacoepidemiology, and advanced research methodology. He is currently based in Shanghai.